![]() |
| Alginate microparticles containing isolated bacterial strains (white particles) and a fecal transplant (brown particles), with a zoom on the structure of the microparticles by scanning electron microscopy. Image Credits: © Adèle Rakotonirina et Nathalie Boulens (CC BY-NC-ND 4.0) |
A UNIGE team, in collaboration with the CHUV, has developed a new method of encapsulating fecal bacteria to treat a serious intestinal infection.
Clostridioides difficile infection causes severe diarrhea and results in the death of nearly 20,000 patients in Europe each year. It is one of the most common hospital-acquired infections. When it relapses, the disease must be treated by fecal microbiota transplantation. This treatment, which is administered via a nasogastric or colorectal tube, is very demanding. Researchers at the University of Geneva (UNIGE), in collaboration with the Lausanne University Hospital (CHUV), have developed small beads to be taken orally, which could radically improve its administration. This work can be found in the International Journal of Pharmaceutics.
Naturally found in 15% of the population, Clostridioides difficile is a bacterium that can become pathogenic when the protective "barriers" of our intestinal flora are weakened. This is particularly the case after prolonged and repeated use of antibiotics. Clostridioides difficile then causes severe diarrhea and can lead to a critical inflammation of the colon, known as pseudomembranous colitis. With more than 124,000 cases per year in Europe, it is one of the most common hospital-acquired infections and is fatal in about 15% of cases.
_1.jpg)

.jpg)
.jpg)


.jpg)
.jpg)
